NCT05950139
- Conditions
- ALK Fusion Protein Expression, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Clinical trial condition
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
NCT05950139
NCT06218914
NCT02682667
NCT07388524
NCT07554339
NCT06066138
NCT05227326
NCT07140315
NCT07630961